tiprankstipranks
Trending News
More News >
Compass Therapeutics, Inc. (CMPX)
:CMPX
US Market
Advertisement

Compass Therapeutics (CMPX) Income Statement

Compare
347 Followers

Compass Therapeutics Income Statement

Last quarter (Q1 2025), Compass Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Compass Therapeutics's net income was $-16.63M. See Compass Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 850.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 850.00K$ -1.89M$ -1.90M$ -1.62M$ -2.40M
Operating Expenses
$ 57.48M$ 48.47M$ 41.66M$ 31.26M$ 27.81M
Depreciation and Amortization
$ 1.75M$ 1.89M$ 1.90M$ 1.62M$ 2.40M
EBITDA
$ -54.87M$ -48.47M$ -37.39M$ -29.61M$ -25.32M
Operating Income
$ -56.63M$ -50.36M$ -41.66M$ -81.88M$ -27.81M
Other Income/Expenses
$ 7.25M$ 7.87M$ 2.43M$ -299.00K$ -1.66M
Pretax Income
$ -49.38M$ -42.49M$ -39.23M$ -82.18M$ -29.47M
Net Income
$ -49.38M$ -42.49M$ -36.80M$ -82.55M$ -29.50M
Per Share Metrics
Basic EPS
$ -0.36$ -0.33$ -0.35$ -1.31$ -0.52
Diluted EPS
$ -0.36$ -0.33$ -0.35$ -1.31$ -0.52
Weighted Average Shares Outstanding
137.11M 127.03M 105.19M 62.87M 56.22M
Weighted Average Shares Outstanding (Diluted)
137.11M 127.03M 105.19M 62.87M 56.22M
Currency in USD

Compass Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis